Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

110 results about "Conjugate acid" patented technology

A conjugate acid, within the Brønsted–Lowry acid–base theory, is a chemical compound formed by the reception of a proton (H⁺) by a base—in other words, it is a base with a hydrogen ion added to it. On the other hand, a conjugate base is what is left over after an acid has donated a proton during a chemical reaction. Hence, a conjugate base is a species formed by the removal of a proton from an acid. Because some acids are capable of releasing multiple protons, the conjugate base of an acid may itself be acidic.yeahh so true In summary, this can be represented as the following chemical reaction...

Sulfonic- functionalized caprolactam acidic ion liquid and preparation method thereof

The invention relates to a chemical product and a preparation technology thereof, in particular to sulfonic-functionalized caprolactam acidic ion liquid and a preparation method thereof. The ion liquid has the following structural general formula shown in the specification, wherein B<-> is selected from the following anions: hydrogen sulfate radicals, p-toluene sulfate radicals, formate radicals, phosphate radicals, and acetate radicals. The preparation method comprises the steps of: firstly, mixing a caprolactam water solution with the concentration of 5-10mol/L with 1,4-butane sultone in the molar ratio of 1:1.1 for reaction for 6-24 h at the temperature of 25-80 DEG C; and then, reacting a reaction product with conjugate acid of the paired anion B<-> in the molar ratio of 1:1 for 4-6h. The preparation method provided by the invention has the advantages that the raw materials are cheap and are easy to obtain and the synthesis steps are simple and convenient and are easy to popularize and apply; the varieties of anions can be adjusted as required so as to satisfy requirements on different acidities so that stronger adjustability is achieved; and the synthesized ion liquid is more degradable than ion liquid of imidazole and pyridine, and is more environmental-friendly and recyclable.
Owner:溧阳常大技术转移中心有限公司

Magnesia coated fluorescent powder and its coating method

InactiveCN1664051AImprove resistance to thermal deteriorationWork lessLuminescent compositionsMagnesium saltSupersonic waves
Disclosed is the magnesia integument phosphor powder covered with magnesia on the surface of the phosphor powder.The method of integument comprising: preparing pH buffer with the concentration between 0.1-0.2M by employing conjugate acid and base system with the pH value between 8.0-12.0, weighing relevant quantity of water-soluble magnesium salt according to the proportion between magnesia and phosphor powder by weight (0.25~15): 100, preparing water-soluble magnesium salt volumetric solution with the concentration between 0.01~1M; preparing phosphor powder suspension with the concentration 0.2~5% by adding the phosphor powder into the buffer, stirring, dispersing with supersonic wave to make the phosphor powder dispersed in the buffer; heating the phosphor powder suspension to 20~70 DEG C and keeping the temperature, stirring with speed 100r/m~ 300r/m and dropping the water-soluble magnesium salt volumetric solution into the phosphor powder suspension at the speed of 2~15ml/min, then keeping the temperature and stirring for 30~180 minutes and getting the integument phosphor powder suspension, separating, washing, dewatering and drying at 60-120DEG C, making the integument phosphor powder moisture percentage below 0.25%,incandescing at 200~400 DEG C for 1~3 hours and air cooling in the furnace.
Owner:SOUTHEAST UNIV

Arsenic-trioxide-carrying pH-responsive mesoporous silica nanoparticle and preparation method thereof

The invention discloses an arsenic-trioxide-carrying pH-responsive mesoporous silica nanoparticle and a preparation method thereof. The preparation method of the arsenic-trioxide-carrying pH-responsive mesoporous silica nanoparticle mainly comprises the following steps: preparing amino modified mesoporous silica by adopting a coprecipitation method, and loading conjugate acid and base ATO and PAA through electrostatic adsorption for preparing PAA-ATO-MSNs. The prepared PAA-ATO-MSNs are circular or quasi-circular in appearance under a transmission electron microscope, average particle size is (158.6+ / -1.32)nm, Zeta potential is (-28.40+ / -0.34)mV, and encapsulation efficiency and drug loading rate are (40.95+ / -3.21)% and (11.42+ / -1.75)% respectively; in vitro drug release is pH-responsive, and accumulated release amount is increased along with reduction of pH value; pharmacokinetic study shows that compared with ATO-Sol and ATO-MSNs, t1 / 2beta of PAA-ATO-MSNs is obviously prolonged and AUC is obviously increased (P is less than 0.01); and PAA-ATO-MSNs in vitro drug release has obvious pH responsiveness and sustained release property, in vivo pharmacokinetic behaviours of a rat can be obviously improved, and the arsenic-trioxide-carrying pH-responsive mesoporous silica nanoparticle carrier can serve as an ATO tumour-targeted drug delivery system and has a good application prospect.
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products